A positive feedback loop couples Ras activation and CD44 alternative splicing

被引:120
作者
Cheng, Chonghui
Yaffe, Michael B.
Sharp, Phillip A.
机构
[1] MIT, Ctr Canc Res, Cambridge, MA 02139 USA
[2] MIT, Dept Biol, Cambridge, MA 02139 USA
关键词
Ras; CD44; variants; alternative splicing; cell cycle;
D O I
10.1101/gad.1430906
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Ras signaling pathway is important in both cell proliferation and tumor progression. Alternatively spliced isoforms of CD44 containing variable exon 6 (v6) can serve as coreceptors for growth factor receptors that activate Ras. Here we use v6-specific small interfering RNA (siRNA) to investigate the role of CD44 alternative splicing in Ras signaling. We identify a positive feedback loop in which Ras signaling promotes CD44v6 splicing, and CD44v6 then sustains late Ras signaling, which is important for cell cycle progression. These results are the first demonstration of a positive feedback loop linking signaling-dependent alternative splicing to mitogenic progression.
引用
收藏
页码:1715 / 1720
页数:6
相关论文
共 26 条
[1]   CD44 ISOFORMS CONTAINING EXON V3 ARE RESPONSIBLE FOR THE PRESENTATION OF HEPARIN-BINDING GROWTH-FACTOR [J].
BENNETT, KL ;
JACKSON, DG ;
SIMON, JC ;
TANCZOS, E ;
PEACH, R ;
MODRELL, B ;
STAMENKOVIC, I ;
PLOWMAN, G ;
ARUFFO, A .
JOURNAL OF CELL BIOLOGY, 1995, 128 (04) :687-698
[2]   Interaction between the adhesion receptor, CD44, and the oncogene product, p185(HER2), promotes human ovarian tumor cell activation [J].
Bourguignon, LYW ;
Zhu, HB ;
Chu, A ;
Iida, N ;
Zhang, L ;
Hung, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :27913-27918
[3]   Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion [J].
Cheng, CH ;
Sharp, PA .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (01) :362-370
[4]   Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells [J].
Cook, SJ ;
McCormick, F .
BIOCHEMICAL JOURNAL, 1996, 320 :237-245
[5]   Identification of a novel inhibitor of mitogen-activated protein kinase kinase [J].
Favata, MF ;
Horiuchi, KY ;
Manos, EJ ;
Daulerio, AJ ;
Stradley, DA ;
Feeser, WS ;
Van Dyk, DE ;
Pitts, WJ ;
Earl, RA ;
Hobbs, F ;
Copeland, RA ;
Magolda, RL ;
Scherle, PA ;
Trzaskos, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :18623-18632
[6]   Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases [J].
Grammer, TC ;
Blenis, J .
ONCOGENE, 1997, 14 (14) :1635-1642
[7]   Proliferation of human malignant astrocytomas is dependent on Ras activation [J].
Guha, A ;
Feldkamp, MM ;
Lau, N ;
Boss, G ;
Pawson, A .
ONCOGENE, 1997, 15 (23) :2755-2765
[8]   A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA-CELLS [J].
GUNTHERT, U ;
HOFMANN, M ;
RUDY, W ;
REBER, S ;
ZOLLER, M ;
HAUSSMANN, I ;
MATZKU, S ;
WENZEL, A ;
PONTA, H ;
HERRLICH, P .
CELL, 1991, 65 (01) :13-24
[9]   Growth-factor-dependent mitogenesis requires two distinct phases of signalling [J].
Jones, SM ;
Kazlauskas, A .
NATURE CELL BIOLOGY, 2001, 3 (02) :165-172
[10]   Growth factor-dependent signaling and cell cycle progression [J].
Jones, SM ;
Kazlauskas, A .
FEBS LETTERS, 2001, 490 (03) :110-116